Diametric Capital, LP Seagen Inc. Transaction History

Diametric Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $18,576 - $20,967	97 Added 0.97%	10,097 $2.14 Million
Q2 2023 Aug 11, 2023	BUY	$187.64 - $206.25 $1.88 Million - $2.06 Million	10,000 New	10,000 $1.92 Million
Q3 2022 Nov 14, 2022	SELL	$135.27 - $180.11 $753,859 - $1 Million	-5,573 Reduced 27.62%	14,605 $2 Million
Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $2.2 Million - $3.62 Million	20,178 New	20,178 $3.57 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Diametric Capital, LP with notifications on news.